DCHS1の変異はミトラ弁の転落を引き起こす
Ronen Durst1,2, Kimberly Sauls3, David S Peal4
1Center for Human Genetic Research, Massachusetts General Hospital Research Institute and Department of Neurology, Harvard Medical School, 185 Cambridge Street, Boston, Massachusetts 02114 USA.
Nature
|August 11, 2015
まとめ
DCHS1遺伝子の遺伝子変異は非症候性ミトラ弁の転落 (MVP) と関連しています. この発見はMVPの遺伝的原因を明らかにし この一般的な心臓病の 治療対象となる可能性があるのです
科学分野:
- 遺伝学
- 心臓病科
- 発達生物学
背景:
- ミトラル弁の転倒 (MVP) は一般的な心臓疾患で,しばしば遺伝的ですが,その遺伝的根拠は不明です.
- MVPはミトラル弁の嘔吐とその後のミトラル弁手術の主な原因です.
研究 の 目的:
- 非症候性ミトラ弁の転落 (MVP) の遺伝的病因を特定する.
主な方法:
- MVPの家族で エクソムの配列が整った
- ゼブラフィッシュ,細胞培養,マウスモデルでの機能研究.
- 患者およびマウスモデルからのミトラル弁のインタースティシャル細胞 (MVIC) の分析.
主要な成果:
- DCHS1遺伝子のミッセンスの変異が特定され,最初の家族でMVPと分離されました.
- さらに2つのファミリーでは,MVPによる異なる有害なDCHS1変異の分離が示された.
- DCHS1の変異はタンパク質の安定性を低下させ,ゼブラフィッシュとマウスの心不全を引き起こし,ミトラ弁の発達とMVICの機能に影響する.
結論:
- DCHS1変異は非症候性ミトラ弁の転落の重要な原因である.
- DCHS1の障害はミトラ弁の形態変異,MVICの移動,細胞のパターン形成に影響する.
- MVPの病原性におけるDCHS1の役割を理解すると,新しい治療戦略につながる可能性があります.
関連する概念動画
Mitral Valve Prolapse I: Introduction
945
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
945
Mitral Stenosis I: Introduction
1.4K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
732
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
732
Mitral Regurgitation I: Introduction
1.1K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.1K
Mitral Valve Prolapse II: Assessment and Management
1.1K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.1K
Sex-linked Disorders
111.5K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
111.5K


